NALOTTO, LINDA
 Distribuzione geografica
Continente #
NA - Nord America 655
AS - Asia 55
EU - Europa 44
OC - Oceania 1
Totale 755
Nazione #
US - Stati Uniti d'America 655
CN - Cina 35
SE - Svezia 11
FI - Finlandia 10
SG - Singapore 9
GB - Regno Unito 8
VN - Vietnam 8
IT - Italia 6
DE - Germania 5
IN - India 3
NL - Olanda 2
CZ - Repubblica Ceca 1
NZ - Nuova Zelanda 1
UA - Ucraina 1
Totale 755
Città #
Fairfield 115
Chandler 77
Woodbridge 77
Ann Arbor 57
Ashburn 50
Houston 48
Cambridge 41
Seattle 37
Wilmington 32
New York 12
San Diego 11
Beijing 9
Des Moines 8
Dong Ket 8
Medford 8
Princeton 8
Dearborn 7
Boardman 5
Helsinki 4
Shenyang 4
Guangzhou 3
Jinan 3
Nanjing 3
Singapore 3
Amsterdam 2
Caorle 2
Hefei 2
Jiaxing 2
London 2
Ogden 2
Taizhou 2
Tianjin 2
Borås 1
Changsha 1
Fuzhou 1
Indiana 1
Lanzhou 1
Los Angeles 1
Milan 1
Milton Keynes 1
Nanchang 1
Olomouc 1
Padova 1
Washington 1
Totale 658
Nome #
Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus. 172
17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. 112
Prolonged remission in Caucasian patients with SLE: prevalence and outcomes 103
Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies 99
Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature. 92
Premature coronary heart disease in SLE: can we prevent progression? 86
The body against self: autoinflammation and autoimmunity. 67
The Management of Systemic Lupus Erythematosus (SLE) Patients in Remission 33
Totale 764
Categoria #
all - tutte 2.517
article - articoli 2.517
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020177 17 3 3 19 20 18 24 17 21 14 11 10
2020/2021123 3 8 4 7 0 5 7 9 12 36 21 11
2021/2022113 1 4 13 19 7 6 1 17 3 1 5 36
2022/2023126 20 16 4 22 16 12 0 11 22 0 1 2
2023/202464 5 2 10 4 2 23 3 1 3 1 5 5
Totale 764